United States Biotechnology & Medical Research

Windtree Therapeutics Inc (WINT)

Track

Ticker: WINT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Windtree Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 8 Oct 2024
Value US$1,482,879.84 | Price 137.99 | Shares 86,330 (+0.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-09 2024-10-08 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
86,330 +0.7%
137.99
US$1,482,880 		86,330 +0.7% 137.99 US$1,482,880
2023-09-28 2023-09-27 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
55,108 -24.2%
35.71
US$1,035,031 		55,108 -24.2% 35.71 US$1,035,031
2023-09-27 2023-09-26 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
51,716 +14.0%
163.47
US$3,939,145 		51,716 +14.0% 163.47 US$3,939,145
2023-04-27 2023-04-26 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
1,497 +27.2%
1.77
US$2,650 		1,497 +27.2% 1.77 US$2,650
2023-04-26 2023-04-25 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
1,315 +31.3%
1.89
US$2,485 		1,315 +31.3% 1.89 US$2,485
2022-07-27 2022-07-27 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
2,500 +1.1%
0.38
US$950 		2,500 +1.1% 0.38 US$950
2022-07-26 2022-07-26 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
2,500 +1.1%
0.37
US$935 		2,500 +1.1% 0.37 US$935
2022-07-26 2022-07-26 B Purchase
2.6
Hamill John P.

SVP & CFO

Officer
3,000 +4.3%
0.37
US$1,100 		3,000 +4.3% 0.37 US$1,100
2022-07-05 2022-06-30 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
4,500 +2.1%
0.43
US$1,926 		4,500 +2.1% 0.43 US$1,926
2022-03-17 2022-03-16 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
2,000 +1.0%
0.98
US$1,960 		2,000 +1.0% 0.98 US$1,960
2022-03-15 2022-03-15 B Purchase
1.8
Simonson Steven

SVP, Chief Medical Officer

Officer
5,000 +6.4%
1.00
US$4,999 		5,000 +6.4% 1.00 US$4,999
2022-03-15 2022-03-15 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
3,000 +1.5%
0.98
US$2,940 		3,000 +1.5% 0.98 US$2,940
2022-01-10 2021-12-30 S Sale
1.7
Bioengine Capital Inc.
Large shareholder
1,239,088 -100.0%
1.60
US$1,982,541 		1,239,088 -100.0% 1.60 US$1,982,541
2022-01-10 2021-12-30 B Purchase
1.7
Center Laboratories, Inc.
Large shareholder
1,239,088 +inf%
1.60
US$1,982,541 		1,239,088 +inf% 1.60 US$1,982,541
2021-11-22 2021-11-19 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
930 +2.5%
1.60
US$1,488 		930 +2.5% 1.60 US$1,488
2021-11-18 2021-11-18 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
930 +2.6%
1.61
US$1,497 		930 +2.6% 1.61 US$1,497
2021-10-25 2021-10-22 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
3,000 +9.0%
1.90
US$5,700 		3,000 +9.0% 1.90 US$5,700
2021-10-19 2021-10-19 B Purchase
2.4
Huang James
Non-Executive Director
50,000 +20.7%
1.90
US$95,135 		50,000 +20.7% 1.90 US$95,135
2021-10-19 2021-10-19 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
3,000 +9.9%
1.91
US$5,730 		3,000 +9.9% 1.91 US$5,730
2021-04-20 2021-04-16 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
1,000 +3.4%
2.09
US$2,092 		1,000 +3.4% 2.09 US$2,092
2021-04-19 2021-04-15 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
1,000 +3.5%
2.24
US$2,240 		1,000 +3.5% 2.24 US$2,240
2021-04-07 2021-04-06 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
500 +1.8%
2.57
US$1,285 		500 +1.8% 2.57 US$1,285
2021-04-06 2021-04-05 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
1,000 +3.7%
2.58
US$2,580 		1,000 +3.7% 2.58 US$2,580
2021-04-05 2021-04-01 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
500 +1.9%
2.46
US$1,229 		500 +1.9% 2.46 US$1,229
2021-04-02 2021-03-31 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
150,000 +714.3%
2.36
US$354,000 		150,000 +714.3% 2.36 US$354,000
2021-03-25 2021-03-25 B Purchase
2.6
Hamill John P.

SVP & CFO

Officer
1,500 +150.0%
3.25
US$4,875 		1,500 +150.0% 3.25 US$4,875
2021-03-25 2021-03-25 B Purchase
1.8
Simonson Steven

SVP, Chief Medical Officer

Officer
1,500 +13.9%
3.25
US$4,875 		1,500 +13.9% 3.25 US$4,875
2021-03-25 2021-03-25 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
1,500 +6.2%
3.25
US$4,875 		1,500 +6.2% 3.25 US$4,875
2020-10-29 2020-10-28 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
250 +1.0%
6.56
US$1,640 		250 +1.0% 6.56 US$1,640
2020-10-27 2020-10-23 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
1,000 +5.0%
6.67
US$6,666 		1,000 +5.0% 6.67 US$6,666
2020-10-13 2020-10-09 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
250 +1.1%
5.83
US$1,456 		250 +1.1% 5.83 US$1,456
2020-10-09 2020-10-08 B Purchase
2.9
Curtis Eric

SVP & COO

Officer
500 +inf%
5.27
US$2,635 		500 +inf% 5.27 US$2,635
2020-10-09 2020-10-07 B Purchase
2.6
Hamill John P.

SVP & CFO

Officer
1,000 +inf%
5.27
US$5,270 		1,000 +inf% 5.27 US$5,270
2020-10-09 2020-10-07 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
250 +1.1%
5.17
US$1,292 		250 +1.1% 5.17 US$1,292
2020-06-05 2020-06-04 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
12,200 +152.5%
7.32
US$89,332 		12,200 +152.5% 7.32 US$89,332
2020-06-05 2020-06-03 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
200 +2.6%
7.42
US$1,484 		200 +2.6% 7.42 US$1,484
2020-05-27 2020-05-22 B Purchase
1.7
Tattory John A

SVP & CFO

Officer
449 +5.1%
7.25
US$3,255 		449 +5.1% 7.25 US$3,255
2020-05-27 2020-05-22 B Purchase
1.7
Schreiber Brian D
Non-Executive Director
2,069 +inf%
7.25
US$15,000 		2,069 +inf% 7.25 US$15,000
2020-05-27 2020-05-22 B Purchase
1.7
PEACOCK BRUCE
Non-Executive Director
3,500 +65.0%
7.25
US$25,375 		3,500 +65.0% 7.25 US$25,375
2020-05-27 2020-05-22 B Purchase
1.7
Templeton Mary B Esq

SVP, Gen Counsel & Corp Sec

Officer
1,103 +3558.1%
7.25
US$7,997 		1,103 +3558.1% 7.25 US$7,997
2020-05-27 2020-05-22 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
275,862 +13.4%
7.25
US$2,000,000 		275,862 +13.4% 7.25 US$2,000,000
2020-05-27 2020-05-22 B Purchase
1.7
Joseph Mahady M
Non-Executive Director
2,069 +38.4%
7.25
US$15,000 		2,069 +38.4% 7.25 US$15,000
2020-05-27 2020-05-22 B Purchase
1.8
Simonson Steven

SVP, Chief Medical Officer

Officer
517 +5.0%
7.25
US$3,748 		517 +5.0% 7.25 US$3,748
2020-05-27 2020-05-22 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
2,069 +9.6%
7.25
US$15,000 		2,069 +9.6% 7.25 US$15,000
2020-05-27 2020-05-22 B Purchase
1.7
Leone John R
Non-Executive Director
2,069 +38.3%
7.25
US$15,000 		2,069 +38.3% 7.25 US$15,000
2020-05-27 2020-05-22 B Purchase
1.4
Geffken Daniel E.
Non-Executive Director
2,069 +inf%
7.25
US$15,000 		2,069 +inf% 7.25 US$15,000
2022-01-10 2020-05-20 B Purchase
1.7
Bioengine Capital Inc.
Large shareholder
55,172 +4.7%
7.25
US$399,997 		55,172 +4.7% 7.25 US$399,997
2022-01-10 2020-05-20 B Purchase
1.7
Center Laboratories, Inc.
Large shareholder
55,172 +4.7%
7.25
US$399,997 		55,172 +4.7% 7.25 US$399,997
2020-02-20 2020-02-18 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
400 +1.7%
3.84
US$1,535 		400 +1.7% 3.84 US$1,535
2020-02-12 2020-02-11 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
250 +0.4%
4.10
US$1,025 		250 +0.4% 4.10 US$1,025
2020-02-12 2020-02-10 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
250 +0.4%
4.10
US$1,025 		250 +0.4% 4.10 US$1,025
2020-02-07 2020-02-07 B Purchase
2.4
Huang James
Non-Executive Director Large shareholder
500 +2.2%
4.05
US$2,025 		500 +2.2% 4.05 US$2,025
2020-02-05 2020-02-04 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
500 +0.8%
4.24
US$2,120 		500 +0.8% 4.24 US$2,120
2020-02-05 2020-02-03 B Purchase
2.2
Fraser Craig

President and CEO

Executive Director
100 +0.2%
4.20
US$420 		100 +0.2% 4.20 US$420
2020-01-21 2020-01-17 B Purchase
2.4
Huang James
Large shareholder
2,000 +9.8%
4.18
US$8,366 		2,000 +9.8% 4.18 US$8,366
2020-01-21 2020-01-16 B Purchase
2.4
Huang James
Large shareholder
58 +0.3%
4.20
US$244 		58 +0.3% 4.20 US$244
2020-01-03 2019-12-31 B Purchase
2.4
Huang James
Large shareholder
15,442 +308.8%
4.05
US$62,525 		15,442 +308.8% 4.05 US$62,525
2019-12-31 2019-12-30 B Purchase Huang James Non-Executive Director Large shareholder
909 +22.2%
3.81
US$3,463 		909 +22.2% 3.81 US$3,463
2019-12-31 2019-12-27 B Purchase Huang James Non-Executive Director Large shareholder
4,091 +inf%
3.73
US$15,261 		4,091 +inf% 3.73 US$15,261
2019-12-10 2019-12-06 B Purchase LPH II Investments Ltd Large shareholder
1,655,629 +70.4%
3.02
US$5,000,000 		1,655,629 +70.4% 3.02 US$5,000,000
2019-12-10 2019-12-06 B Purchase Huang James Non-Executive Director Large shareholder
1,655,629 +36.6%
3.02
US$5,000,000 		1,655,629 +36.6% 3.02 US$5,000,000
2019-12-10 2019-12-06 B Purchase Lee's Pharmaceutical Holdings Ltd Large shareholder
1,655,629 +12.9%
3.02
US$5,000,000 		1,655,629 +12.9% 3.02 US$5,000,000
2018-04-06 2018-04-04 B Purchase Lee's Pharmaceutical Holdings Ltd Large shareholder
541,667 +23.4%
4.80
US$2,600,002 		541,667 +23.4% 4.80 US$2,600,002
2016-11-01 2016-10-28 B Purchase Fraser Craig

President and CEO

Executive Director
7,500 +inf%
2.05
US$15,381 		7,500 +inf% 2.05 US$15,381
2013-02-20 2013-02-19 B Purchase Leone John R Non-Executive Director
3,000 +inf%
2.88
US$8,640 		3,000 +inf% 2.88 US$8,640
2010-12-21 2010-12-17 S Sale LOPEZ DAVID L

Executive VP & Legal Counsel

Officer
16,300 -5.9%
0.21
US$3,449 		16,300 -5.9% 0.21 US$3,449
2010-12-21 2010-12-17 S Sale LOPEZ DAVID L

Executive VP & Legal Counsel

Officer
700 -0.3%
0.21
US$148 		700 -0.3% 0.21 US$148
2008-11-20 2008-11-20 B Purchase ROSENTHALE MARVIN E Non-Executive Director
14,674 +7.0%
0.90
US$13,133 		14,674 +7.0% 0.90 US$13,133
2008-11-20 2008-11-20 B Purchase ROSENTHALE MARVIN E Non-Executive Director
500 +0.4%
0.91
US$453 		500 +0.4% 0.91 US$453
2008-11-20 2008-11-19 B Purchase ROSENTHALE MARVIN E Non-Executive Director
9,655 +4.8%
0.93
US$8,979 		9,655 +4.8% 0.93 US$8,979
2008-11-20 2008-11-19 B Purchase ROSENTHALE MARVIN E Non-Executive Director
23,400 +23.1%
0.93
US$21,762 		23,400 +23.1% 0.93 US$21,762
2008-11-20 2008-11-18 B Purchase ROSENTHALE MARVIN E Non-Executive Director
25,671 +14.7%
1.00
US$25,671 		25,671 +14.7% 1.00 US$25,671
2008-11-20 2008-11-18 B Purchase ROSENTHALE MARVIN E Non-Executive Director
1,100 +1.1%
1.00
US$1,100 		1,100 +1.1% 1.00 US$1,100
2008-11-17 2008-11-17 B Purchase CAPETOLA ROBERT J

President/CEO

Executive Director
40,000 +10.1%
1.01
US$40,400 		40,000 +10.1% 1.01 US$40,400
2008-11-17 2008-11-17 B Purchase CAPETOLA ROBERT J

President/CEO

Executive Director
10,000 +2.3%
1.05
US$10,450 		10,000 +2.3% 1.05 US$10,450
Explore more

More insider trading research around Windtree Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America